The Latest in FDA Evaluations and Research

FDA News

Related Topics: Pediatrics Journal, FDA News, Government News, Pharmaceutical News

News Feed Item

Video: National Association of School Nurses Launches 'Back to School' Campaign to Educate Parents, Community About Head Lice

Six to 12 Million Children, Including One in Every 100 Elementary School Kids, Are Infested Each Year

SILVER SPRING, Md., Sept. 14 /PRNewswire/ -- The National Association of School Nurses (NASN) announced today the kickoff of S.C.R.A.T.C.H. (School and Community Resources to Avoid and Take Control of Head Lice), a campaign to educate school nurses, students, parents and the general public about the prevention and control of head lice. NASN has teamed up with Sciele Pharma, Inc., a Shionogi company, on the multi-faceted program, which is being launched as children throughout the U.S. head back to school, an environment where head lice is most prevalent.

To view the Multimedia News Release, go to:

Each year approximately six to 12 million children between 3 and 12 years of age are infested with head lice(1,4). ,About one in every 100 U.S. elementary school children will be infested with head lice(5).

"As the onsite health professionals in schools, school nurses are in an excellent position to provide education to students, parents, their school colleagues and the community about head lice, a challenging and often misunderstood medical condition that causes anxiety among those affected," said Sandra Delack, RN, MEd, NCSN, NASN President. "This program will provide the facts about the causes, prevention and management of head lice, and hopefully serve to dispel the myths and stigmas regarding lice infestation."

Components of the S.C.R.A.T.C.H. program include such Web-based educational resources as a fact sheet on head lice for school nurses and other school professionals; a slide kit on head lice prevention and management for school nurse presentations to school and community groups; and a "Dear Parent" letter and fact sheet with "frequently asked questions" for parents on this topic.

NASN will promote the S.C.R.A.T.C.H. program among its 14,000 members to reach schools, students and their parents and guardians around the country. For more information on the program, visit

Sciele Pharma, Inc., a Shionogi company, provided support for the program.

About Head Lice

Generally found on the scalp, around the ears and at the back of the neck, the adult louse is about the size of a sesame seed and can be a reddish-brown color(2). Eggs, or nits, are smaller and are silver in color(3). The most common symptom of head lice is head scratching caused by sensitivity to the louse's saliva(1), although red bite marks may also be noticed(2). While lice are not considered an infectious disease, transmission from one individual to another can occur during direct contact or through the sharing of personal items such as hats, helmets, brushes or combs(1). Lice are not a sign of poor hygiene and they do not transmit disease.

Traditional treatments for head lice include nit picking with a fine-tooth comb, over-the-counter and prescription products, and home remedies. Many products contain a pesticide that is neurotoxic. These products are safe and effective but like all medical treatments, they must be used as directed and with caution by parents. Also, studies have shown that head lice are learning to outsmart many neurotoxic pesticides and are developing resistance to these products, in much the same way that some bacteria have developed resistance to antibiotics. (2,3) The U.S. Food and Drug Administration (FDA) recently approved the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects.

About NASN

The National Association of School Nurses is a non-profit specialty nursing organization, organized in 1968 and incorporated in 1977, representing school nurses exclusively. NASN has over 14,000 members and 51 affiliates, including the District of Columbia and overseas. The mission of the NASN is "to improve the health and educational success of children and youth by developing and providing leadership to advance the school nursing practice." To learn more about the NASN, please visit us on the Web at

About Sciele Pharma, Inc.

Sciele Pharma, Inc., a Shionogi company, is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on the therapeutic areas of Cardiovascular, Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular and Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, coughs and colds, and attention deficit and hyperactivity disorder (ADHD). Founded in 1992 and headquartered in Atlanta, Georgia, Sciele employs more than 1,000 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Execution Excellence, Simplicity, and Teamwork.

On October 9, 2008, Shionogi & co., ltd. and Sciele Pharma announced the completion of Shionogi's acquisition of Sciele. Sciele is now an indirect wholly owned subsidiary of Shionogi.

About Shionogi & co., ltd.

Shionogi & co., ltd. is a major research-driven Japanese pharmaceutical manufacturer. The company's primary businesses are research and development, manufacturing, marketing, and import and export sales of pharmaceuticals and diagnostics. Shionogi follows a basic policy of continually providing the superior medicines essential to people's health. For more details, please visit


    (1) Frankowski, B.L., Weiner, L.B, the Committee on School Health, the Committee on Infectious Disease (September 2002).
    American Academy of Pediatrics Clinical Report: Guidance for the Clinician in Rendering Pediatric Care: Head Lice. Pediatrics, 110 (3).
    (2) Head Lice Control. Beyond Pesticides/NCAMP fact sheet.
    (3) Hansen, R.C (September 2004). Overview: The State of Head Lice Management and Control. Am J Manag Care, 10, S250-S263.
    (4) Williams, L., Reichert, A., MacKenzie, W., Hightower, A., & Blake, P. (2001). Lice, nits, and school policy. Pediatrics. 107(5). 1011-1015.
    (5) Pollack, R.J. The Role of the School in Battling Head Lice. Our Children Magazine

S.C.R.A.T.C.H. is a patient education program sponsored by Sciele Pharma, Inc., a Shionogi company. All rights reserved.

    Press Contacts:
    Karen Dombek
    MCS Healthcare Public Relations
    (800) 477-9626, ext. 319
    [email protected]

    Kenny Lull
    National Association of School Nurses
    [email protected]

SOURCE National Association of School Nurses

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.